Evidence map›Paper›PMID 35005561›Full record

ArticleiScience2022

Peripheral immunophenotyping of AITD subjects reveals alterations in immune cells in pediatric vs adult-onset AITD.

Zachary C Stensland, Brianne M Coleman, Marynette Rihanek, Ryan M Baxter, Peter A Gottlieb, Elena W Y Hsieh, Virginia D Sarapura, Kimber M Simmons, John C Cambier, Mia J Smith

Open access · goldAbstract read
In one paragraph

Article in iScience, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
0.5field-weighted citation impact, top 38% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 9 citations in OpenAlex.

  1. Article
  2. The diverseFrontiers in immunology · 2025
    Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 3 institutions in 1 country.

Zachary C StenslandDepartment of Pediatrics, University of Colorado School of Medicine, Aurora, CO 80045, USA.
Brianne M ColemanDepartment of Immunology and Microbiology, University of Colorado School of Medicine, Aurora, CO 80045, USA.
Marynette RihanekBarbara Davis Center for Diabetes, University of Colorado School of Medicine, Aurora, CO 80045, USA.
Ryan M BaxterDepartment of Immunology and Microbiology, University of Colorado School of Medicine, Aurora, CO 80045, USA.
Peter A GottliebBarbara Davis Center for Diabetes, University of Colorado School of Medicine, Aurora, CO 80045, USA.
Elena W Y HsiehDepartment of Immunology and Microbiology, University of Colorado School of Medicine, Aurora, CO 80045, USA.
Virginia D SarapuraDivision of Endocrinology, Metabolism, and Diabetes, University of Colorado Health Sciences Center, Aurora, CO 80045, USA.
Kimber M SimmonsBarbara Davis Center for Diabetes, University of Colorado School of Medicine, Aurora, CO 80045, USA.
John C CambierDepartment of Immunology and Microbiology, University of Colorado School of Medicine, Aurora, CO 80045, USA.
Mia J SmithDepartment of Pediatrics, University of Colorado School of Medicine, Aurora, CO 80045, USA.
University of Colorado Denver · USChildren's Hospital Colorado · USUniversity of Colorado Health · US

Funding

University of Colorado Anschutz Medical Campus DRCP30DK116073 · NIDDK · UNIVERSITY OF COLORADO DENVER · PI LORI SUSSEL · 2020 to 2026
$10.8M
Autoimmunity risk alleles compromising B cell anergyR01AI124487 · NIAID · UNIVERSITY OF COLORADO DENVER · PI CAMBIER, JOHN C · 2016 to 2020
$2.5M
Immune Dysregulation in Pediatric SLE PathogenesisK23AR070897 · NIAMS · UNIVERSITY OF COLORADO DENVER · PI HSIEH, WEN-YUAN E · 2017 to 2021
$850k
Genetic contribution to loss of B cell anergy during development of type 1 diabetesK01OD028759 · OD · UNIVERSITY OF COLORADO DENVER · PI SMITH, MIA · 2020 to 2024
$567k
Perturbation of B cell anergy in T1DR21AI124488 · NIAID · UNIVERSITY OF COLORADO DENVER · PI CAMBIER, JOHN C · 2016 to 2017
$428k
Genetic risk alleles as drivers of loss of anergic B cells in autoimmunityF30OD021477 · OD · COLORADO STATE UNIVERSITY · PI SMITH, MIA · 2016 to 2017
$79k
NIAID NIH HHS L40 AI154487NIAID NIH HHS R01 AI124487NIAID NIH HHS R21 AI124488NIAMS NIH HHS K23 AR070897NIDDK NIH HHS P30 DK116073NIH HHS F30 OD021477NIH HHS K01 OD028759
6 · The paper itself

Abstract

Autoimmune thyroid disease (AITD) is caused by aberrant activation of the immune system allowing autoreactive B and T cells to target the thyroid gland leading to disease. Although AITD is more frequently diagnosed in adults, children are also affected but rarely studied. Here, we performed phenotypic and functional characterization of peripheral blood immune cells from pediatric and adult-onset AITD patients and age-matched controls using mass cytometry. Major findings indicate that unlike adult-onset AITD patients, pediatric AITD patients exhibit a decrease in anergic B cells (B

Indexed as

Cell biologyImmunological methodsImmunology

Identifiers

PMID35005561
PMCPMC8718984
OpenAlexW4200200608

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.